Medical Care
Global Digital Therapeutics for Psychiatric Illnesses Market Research Report 2025
- May 05, 25
- ID: 227201
- Pages: 73
- Figures: 74
- Views: 41
The global market for Digital Therapeutics for Psychiatric Illnesses was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Digital Therapeutics for Psychiatric Illnesses are software program-driven, evidence-based interventions for the treatment, management or prevention of psychiatric illnesses.
North American market for Digital Therapeutics for Psychiatric Illnesses is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Digital Therapeutics for Psychiatric Illnesses is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Digital Therapeutics for Psychiatric Illnesses in Insomnia is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Digital Therapeutics for Psychiatric Illnesses include Pear Therapeutics, Akili Interactive, Big Health, Click Therapeutics, Orexo, Limbix, Cognoa, Freespira, Shandong Xindao Artificial Intelligence Technology Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Digital Therapeutics for Psychiatric Illnesses, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Digital Therapeutics for Psychiatric Illnesses.
The Digital Therapeutics for Psychiatric Illnesses market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Digital Therapeutics for Psychiatric Illnesses market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Digital Therapeutics for Psychiatric Illnesses companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pear Therapeutics
Akili Interactive
Big Health
Click Therapeutics
Orexo
Limbix
Cognoa
Freespira
Shandong Xindao Artificial Intelligence Technology Co., Ltd.
Segment by Type
Prevention
Management
Treatment
Segment by Application
Insomnia
Depression
Autistic
Anxiety Disorder
Schizophrenia
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Digital Therapeutics for Psychiatric Illnesses company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Digital Therapeutics for Psychiatric Illnesses are software program-driven, evidence-based interventions for the treatment, management or prevention of psychiatric illnesses.
North American market for Digital Therapeutics for Psychiatric Illnesses is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Digital Therapeutics for Psychiatric Illnesses is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Digital Therapeutics for Psychiatric Illnesses in Insomnia is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Digital Therapeutics for Psychiatric Illnesses include Pear Therapeutics, Akili Interactive, Big Health, Click Therapeutics, Orexo, Limbix, Cognoa, Freespira, Shandong Xindao Artificial Intelligence Technology Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Digital Therapeutics for Psychiatric Illnesses, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Digital Therapeutics for Psychiatric Illnesses.
The Digital Therapeutics for Psychiatric Illnesses market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Digital Therapeutics for Psychiatric Illnesses market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Digital Therapeutics for Psychiatric Illnesses companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pear Therapeutics
Akili Interactive
Big Health
Click Therapeutics
Orexo
Limbix
Cognoa
Freespira
Shandong Xindao Artificial Intelligence Technology Co., Ltd.
Segment by Type
Prevention
Management
Treatment
Segment by Application
Insomnia
Depression
Autistic
Anxiety Disorder
Schizophrenia
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Digital Therapeutics for Psychiatric Illnesses company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Digital Therapeutics for Psychiatric Illnesses Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Prevention
1.2.3 Management
1.2.4 Treatment
1.3 Market by Application
1.3.1 Global Digital Therapeutics for Psychiatric Illnesses Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Insomnia
1.3.3 Depression
1.3.4 Autistic
1.3.5 Anxiety Disorder
1.3.6 Schizophrenia
1.3.7 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Digital Therapeutics for Psychiatric Illnesses Market Perspective (2020-2031)
2.2 Global Digital Therapeutics for Psychiatric Illnesses Growth Trends by Region
2.2.1 Global Digital Therapeutics for Psychiatric Illnesses Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Digital Therapeutics for Psychiatric Illnesses Historic Market Size by Region (2020-2025)
2.2.3 Digital Therapeutics for Psychiatric Illnesses Forecasted Market Size by Region (2026-2031)
2.3 Digital Therapeutics for Psychiatric Illnesses Market Dynamics
2.3.1 Digital Therapeutics for Psychiatric Illnesses Industry Trends
2.3.2 Digital Therapeutics for Psychiatric Illnesses Market Drivers
2.3.3 Digital Therapeutics for Psychiatric Illnesses Market Challenges
2.3.4 Digital Therapeutics for Psychiatric Illnesses Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Digital Therapeutics for Psychiatric Illnesses Players by Revenue
3.1.1 Global Top Digital Therapeutics for Psychiatric Illnesses Players by Revenue (2020-2025)
3.1.2 Global Digital Therapeutics for Psychiatric Illnesses Revenue Market Share by Players (2020-2025)
3.2 Global Digital Therapeutics for Psychiatric Illnesses Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Digital Therapeutics for Psychiatric Illnesses Revenue
3.4 Global Digital Therapeutics for Psychiatric Illnesses Market Concentration Ratio
3.4.1 Global Digital Therapeutics for Psychiatric Illnesses Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Digital Therapeutics for Psychiatric Illnesses Revenue in 2024
3.5 Global Key Players of Digital Therapeutics for Psychiatric Illnesses Head office and Area Served
3.6 Global Key Players of Digital Therapeutics for Psychiatric Illnesses, Product and Application
3.7 Global Key Players of Digital Therapeutics for Psychiatric Illnesses, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Digital Therapeutics for Psychiatric Illnesses Breakdown Data by Type
4.1 Global Digital Therapeutics for Psychiatric Illnesses Historic Market Size by Type (2020-2025)
4.2 Global Digital Therapeutics for Psychiatric Illnesses Forecasted Market Size by Type (2026-2031)
5 Digital Therapeutics for Psychiatric Illnesses Breakdown Data by Application
5.1 Global Digital Therapeutics for Psychiatric Illnesses Historic Market Size by Application (2020-2025)
5.2 Global Digital Therapeutics for Psychiatric Illnesses Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Digital Therapeutics for Psychiatric Illnesses Market Size (2020-2031)
6.2 North America Digital Therapeutics for Psychiatric Illnesses Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2020-2025)
6.4 North America Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Digital Therapeutics for Psychiatric Illnesses Market Size (2020-2031)
7.2 Europe Digital Therapeutics for Psychiatric Illnesses Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2020-2025)
7.4 Europe Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Digital Therapeutics for Psychiatric Illnesses Market Size (2020-2031)
8.2 Asia-Pacific Digital Therapeutics for Psychiatric Illnesses Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Digital Therapeutics for Psychiatric Illnesses Market Size by Region (2020-2025)
8.4 Asia-Pacific Digital Therapeutics for Psychiatric Illnesses Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Digital Therapeutics for Psychiatric Illnesses Market Size (2020-2031)
9.2 Latin America Digital Therapeutics for Psychiatric Illnesses Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2020-2025)
9.4 Latin America Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size (2020-2031)
10.2 Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2020-2025)
10.4 Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pear Therapeutics
11.1.1 Pear Therapeutics Company Details
11.1.2 Pear Therapeutics Business Overview
11.1.3 Pear Therapeutics Digital Therapeutics for Psychiatric Illnesses Introduction
11.1.4 Pear Therapeutics Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)
11.1.5 Pear Therapeutics Recent Development
11.2 Akili Interactive
11.2.1 Akili Interactive Company Details
11.2.2 Akili Interactive Business Overview
11.2.3 Akili Interactive Digital Therapeutics for Psychiatric Illnesses Introduction
11.2.4 Akili Interactive Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)
11.2.5 Akili Interactive Recent Development
11.3 Big Health
11.3.1 Big Health Company Details
11.3.2 Big Health Business Overview
11.3.3 Big Health Digital Therapeutics for Psychiatric Illnesses Introduction
11.3.4 Big Health Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)
11.3.5 Big Health Recent Development
11.4 Click Therapeutics
11.4.1 Click Therapeutics Company Details
11.4.2 Click Therapeutics Business Overview
11.4.3 Click Therapeutics Digital Therapeutics for Psychiatric Illnesses Introduction
11.4.4 Click Therapeutics Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)
11.4.5 Click Therapeutics Recent Development
11.5 Orexo
11.5.1 Orexo Company Details
11.5.2 Orexo Business Overview
11.5.3 Orexo Digital Therapeutics for Psychiatric Illnesses Introduction
11.5.4 Orexo Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)
11.5.5 Orexo Recent Development
11.6 Limbix
11.6.1 Limbix Company Details
11.6.2 Limbix Business Overview
11.6.3 Limbix Digital Therapeutics for Psychiatric Illnesses Introduction
11.6.4 Limbix Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)
11.6.5 Limbix Recent Development
11.7 Cognoa
11.7.1 Cognoa Company Details
11.7.2 Cognoa Business Overview
11.7.3 Cognoa Digital Therapeutics for Psychiatric Illnesses Introduction
11.7.4 Cognoa Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)
11.7.5 Cognoa Recent Development
11.8 Freespira
11.8.1 Freespira Company Details
11.8.2 Freespira Business Overview
11.8.3 Freespira Digital Therapeutics for Psychiatric Illnesses Introduction
11.8.4 Freespira Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)
11.8.5 Freespira Recent Development
11.9 Shandong Xindao Artificial Intelligence Technology Co., Ltd.
11.9.1 Shandong Xindao Artificial Intelligence Technology Co., Ltd. Company Details
11.9.2 Shandong Xindao Artificial Intelligence Technology Co., Ltd. Business Overview
11.9.3 Shandong Xindao Artificial Intelligence Technology Co., Ltd. Digital Therapeutics for Psychiatric Illnesses Introduction
11.9.4 Shandong Xindao Artificial Intelligence Technology Co., Ltd. Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)
11.9.5 Shandong Xindao Artificial Intelligence Technology Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Digital Therapeutics for Psychiatric Illnesses Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Prevention
1.2.3 Management
1.2.4 Treatment
1.3 Market by Application
1.3.1 Global Digital Therapeutics for Psychiatric Illnesses Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Insomnia
1.3.3 Depression
1.3.4 Autistic
1.3.5 Anxiety Disorder
1.3.6 Schizophrenia
1.3.7 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Digital Therapeutics for Psychiatric Illnesses Market Perspective (2020-2031)
2.2 Global Digital Therapeutics for Psychiatric Illnesses Growth Trends by Region
2.2.1 Global Digital Therapeutics for Psychiatric Illnesses Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Digital Therapeutics for Psychiatric Illnesses Historic Market Size by Region (2020-2025)
2.2.3 Digital Therapeutics for Psychiatric Illnesses Forecasted Market Size by Region (2026-2031)
2.3 Digital Therapeutics for Psychiatric Illnesses Market Dynamics
2.3.1 Digital Therapeutics for Psychiatric Illnesses Industry Trends
2.3.2 Digital Therapeutics for Psychiatric Illnesses Market Drivers
2.3.3 Digital Therapeutics for Psychiatric Illnesses Market Challenges
2.3.4 Digital Therapeutics for Psychiatric Illnesses Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Digital Therapeutics for Psychiatric Illnesses Players by Revenue
3.1.1 Global Top Digital Therapeutics for Psychiatric Illnesses Players by Revenue (2020-2025)
3.1.2 Global Digital Therapeutics for Psychiatric Illnesses Revenue Market Share by Players (2020-2025)
3.2 Global Digital Therapeutics for Psychiatric Illnesses Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Digital Therapeutics for Psychiatric Illnesses Revenue
3.4 Global Digital Therapeutics for Psychiatric Illnesses Market Concentration Ratio
3.4.1 Global Digital Therapeutics for Psychiatric Illnesses Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Digital Therapeutics for Psychiatric Illnesses Revenue in 2024
3.5 Global Key Players of Digital Therapeutics for Psychiatric Illnesses Head office and Area Served
3.6 Global Key Players of Digital Therapeutics for Psychiatric Illnesses, Product and Application
3.7 Global Key Players of Digital Therapeutics for Psychiatric Illnesses, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Digital Therapeutics for Psychiatric Illnesses Breakdown Data by Type
4.1 Global Digital Therapeutics for Psychiatric Illnesses Historic Market Size by Type (2020-2025)
4.2 Global Digital Therapeutics for Psychiatric Illnesses Forecasted Market Size by Type (2026-2031)
5 Digital Therapeutics for Psychiatric Illnesses Breakdown Data by Application
5.1 Global Digital Therapeutics for Psychiatric Illnesses Historic Market Size by Application (2020-2025)
5.2 Global Digital Therapeutics for Psychiatric Illnesses Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Digital Therapeutics for Psychiatric Illnesses Market Size (2020-2031)
6.2 North America Digital Therapeutics for Psychiatric Illnesses Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2020-2025)
6.4 North America Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Digital Therapeutics for Psychiatric Illnesses Market Size (2020-2031)
7.2 Europe Digital Therapeutics for Psychiatric Illnesses Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2020-2025)
7.4 Europe Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Digital Therapeutics for Psychiatric Illnesses Market Size (2020-2031)
8.2 Asia-Pacific Digital Therapeutics for Psychiatric Illnesses Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Digital Therapeutics for Psychiatric Illnesses Market Size by Region (2020-2025)
8.4 Asia-Pacific Digital Therapeutics for Psychiatric Illnesses Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Digital Therapeutics for Psychiatric Illnesses Market Size (2020-2031)
9.2 Latin America Digital Therapeutics for Psychiatric Illnesses Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2020-2025)
9.4 Latin America Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size (2020-2031)
10.2 Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2020-2025)
10.4 Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pear Therapeutics
11.1.1 Pear Therapeutics Company Details
11.1.2 Pear Therapeutics Business Overview
11.1.3 Pear Therapeutics Digital Therapeutics for Psychiatric Illnesses Introduction
11.1.4 Pear Therapeutics Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)
11.1.5 Pear Therapeutics Recent Development
11.2 Akili Interactive
11.2.1 Akili Interactive Company Details
11.2.2 Akili Interactive Business Overview
11.2.3 Akili Interactive Digital Therapeutics for Psychiatric Illnesses Introduction
11.2.4 Akili Interactive Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)
11.2.5 Akili Interactive Recent Development
11.3 Big Health
11.3.1 Big Health Company Details
11.3.2 Big Health Business Overview
11.3.3 Big Health Digital Therapeutics for Psychiatric Illnesses Introduction
11.3.4 Big Health Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)
11.3.5 Big Health Recent Development
11.4 Click Therapeutics
11.4.1 Click Therapeutics Company Details
11.4.2 Click Therapeutics Business Overview
11.4.3 Click Therapeutics Digital Therapeutics for Psychiatric Illnesses Introduction
11.4.4 Click Therapeutics Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)
11.4.5 Click Therapeutics Recent Development
11.5 Orexo
11.5.1 Orexo Company Details
11.5.2 Orexo Business Overview
11.5.3 Orexo Digital Therapeutics for Psychiatric Illnesses Introduction
11.5.4 Orexo Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)
11.5.5 Orexo Recent Development
11.6 Limbix
11.6.1 Limbix Company Details
11.6.2 Limbix Business Overview
11.6.3 Limbix Digital Therapeutics for Psychiatric Illnesses Introduction
11.6.4 Limbix Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)
11.6.5 Limbix Recent Development
11.7 Cognoa
11.7.1 Cognoa Company Details
11.7.2 Cognoa Business Overview
11.7.3 Cognoa Digital Therapeutics for Psychiatric Illnesses Introduction
11.7.4 Cognoa Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)
11.7.5 Cognoa Recent Development
11.8 Freespira
11.8.1 Freespira Company Details
11.8.2 Freespira Business Overview
11.8.3 Freespira Digital Therapeutics for Psychiatric Illnesses Introduction
11.8.4 Freespira Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)
11.8.5 Freespira Recent Development
11.9 Shandong Xindao Artificial Intelligence Technology Co., Ltd.
11.9.1 Shandong Xindao Artificial Intelligence Technology Co., Ltd. Company Details
11.9.2 Shandong Xindao Artificial Intelligence Technology Co., Ltd. Business Overview
11.9.3 Shandong Xindao Artificial Intelligence Technology Co., Ltd. Digital Therapeutics for Psychiatric Illnesses Introduction
11.9.4 Shandong Xindao Artificial Intelligence Technology Co., Ltd. Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)
11.9.5 Shandong Xindao Artificial Intelligence Technology Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Digital Therapeutics for Psychiatric Illnesses Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Prevention
Table 3. Key Players of Management
Table 4. Key Players of Treatment
Table 5. Global Digital Therapeutics for Psychiatric Illnesses Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Digital Therapeutics for Psychiatric Illnesses Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Digital Therapeutics for Psychiatric Illnesses Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Digital Therapeutics for Psychiatric Illnesses Market Share by Region (2020-2025)
Table 9. Global Digital Therapeutics for Psychiatric Illnesses Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Digital Therapeutics for Psychiatric Illnesses Market Share by Region (2026-2031)
Table 11. Digital Therapeutics for Psychiatric Illnesses Market Trends
Table 12. Digital Therapeutics for Psychiatric Illnesses Market Drivers
Table 13. Digital Therapeutics for Psychiatric Illnesses Market Challenges
Table 14. Digital Therapeutics for Psychiatric Illnesses Market Restraints
Table 15. Global Digital Therapeutics for Psychiatric Illnesses Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Digital Therapeutics for Psychiatric Illnesses Market Share by Players (2020-2025)
Table 17. Global Top Digital Therapeutics for Psychiatric Illnesses Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Therapeutics for Psychiatric Illnesses as of 2024)
Table 18. Ranking of Global Top Digital Therapeutics for Psychiatric Illnesses Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Digital Therapeutics for Psychiatric Illnesses Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Digital Therapeutics for Psychiatric Illnesses, Headquarters and Area Served
Table 21. Global Key Players of Digital Therapeutics for Psychiatric Illnesses, Product and Application
Table 22. Global Key Players of Digital Therapeutics for Psychiatric Illnesses, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Digital Therapeutics for Psychiatric Illnesses Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Digital Therapeutics for Psychiatric Illnesses Revenue Market Share by Type (2020-2025)
Table 26. Global Digital Therapeutics for Psychiatric Illnesses Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Digital Therapeutics for Psychiatric Illnesses Revenue Market Share by Type (2026-2031)
Table 28. Global Digital Therapeutics for Psychiatric Illnesses Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Digital Therapeutics for Psychiatric Illnesses Revenue Market Share by Application (2020-2025)
Table 30. Global Digital Therapeutics for Psychiatric Illnesses Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Digital Therapeutics for Psychiatric Illnesses Revenue Market Share by Application (2026-2031)
Table 32. North America Digital Therapeutics for Psychiatric Illnesses Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Digital Therapeutics for Psychiatric Illnesses Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Digital Therapeutics for Psychiatric Illnesses Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Digital Therapeutics for Psychiatric Illnesses Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Digital Therapeutics for Psychiatric Illnesses Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Digital Therapeutics for Psychiatric Illnesses Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2026-2031) & (US$ Million)
Table 47. Pear Therapeutics Company Details
Table 48. Pear Therapeutics Business Overview
Table 49. Pear Therapeutics Digital Therapeutics for Psychiatric Illnesses Product
Table 50. Pear Therapeutics Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025) & (US$ Million)
Table 51. Pear Therapeutics Recent Development
Table 52. Akili Interactive Company Details
Table 53. Akili Interactive Business Overview
Table 54. Akili Interactive Digital Therapeutics for Psychiatric Illnesses Product
Table 55. Akili Interactive Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025) & (US$ Million)
Table 56. Akili Interactive Recent Development
Table 57. Big Health Company Details
Table 58. Big Health Business Overview
Table 59. Big Health Digital Therapeutics for Psychiatric Illnesses Product
Table 60. Big Health Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025) & (US$ Million)
Table 61. Big Health Recent Development
Table 62. Click Therapeutics Company Details
Table 63. Click Therapeutics Business Overview
Table 64. Click Therapeutics Digital Therapeutics for Psychiatric Illnesses Product
Table 65. Click Therapeutics Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025) & (US$ Million)
Table 66. Click Therapeutics Recent Development
Table 67. Orexo Company Details
Table 68. Orexo Business Overview
Table 69. Orexo Digital Therapeutics for Psychiatric Illnesses Product
Table 70. Orexo Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025) & (US$ Million)
Table 71. Orexo Recent Development
Table 72. Limbix Company Details
Table 73. Limbix Business Overview
Table 74. Limbix Digital Therapeutics for Psychiatric Illnesses Product
Table 75. Limbix Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025) & (US$ Million)
Table 76. Limbix Recent Development
Table 77. Cognoa Company Details
Table 78. Cognoa Business Overview
Table 79. Cognoa Digital Therapeutics for Psychiatric Illnesses Product
Table 80. Cognoa Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025) & (US$ Million)
Table 81. Cognoa Recent Development
Table 82. Freespira Company Details
Table 83. Freespira Business Overview
Table 84. Freespira Digital Therapeutics for Psychiatric Illnesses Product
Table 85. Freespira Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025) & (US$ Million)
Table 86. Freespira Recent Development
Table 87. Shandong Xindao Artificial Intelligence Technology Co., Ltd. Company Details
Table 88. Shandong Xindao Artificial Intelligence Technology Co., Ltd. Business Overview
Table 89. Shandong Xindao Artificial Intelligence Technology Co., Ltd. Digital Therapeutics for Psychiatric Illnesses Product
Table 90. Shandong Xindao Artificial Intelligence Technology Co., Ltd. Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025) & (US$ Million)
Table 91. Shandong Xindao Artificial Intelligence Technology Co., Ltd. Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
Table 95. Authors List of This Report
List of Figures
Figure 1. Digital Therapeutics for Psychiatric Illnesses Picture
Figure 2. Global Digital Therapeutics for Psychiatric Illnesses Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Digital Therapeutics for Psychiatric Illnesses Market Share by Type: 2024 VS 2031
Figure 4. Prevention Features
Figure 5. Management Features
Figure 6. Treatment Features
Figure 7. Global Digital Therapeutics for Psychiatric Illnesses Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Digital Therapeutics for Psychiatric Illnesses Market Share by Application: 2024 VS 2031
Figure 9. Insomnia Case Studies
Figure 10. Depression Case Studies
Figure 11. Autistic Case Studies
Figure 12. Anxiety Disorder Case Studies
Figure 13. Schizophrenia Case Studies
Figure 14. Other Case Studies
Figure 15. Digital Therapeutics for Psychiatric Illnesses Report Years Considered
Figure 16. Global Digital Therapeutics for Psychiatric Illnesses Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Digital Therapeutics for Psychiatric Illnesses Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Digital Therapeutics for Psychiatric Illnesses Market Share by Region: 2024 VS 2031
Figure 19. Global Digital Therapeutics for Psychiatric Illnesses Market Share by Players in 2024
Figure 20. Global Top Digital Therapeutics for Psychiatric Illnesses Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Therapeutics for Psychiatric Illnesses as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Digital Therapeutics for Psychiatric Illnesses Revenue in 2024
Figure 22. North America Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Digital Therapeutics for Psychiatric Illnesses Market Share by Country (2020-2031)
Figure 24. United States Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Digital Therapeutics for Psychiatric Illnesses Market Share by Country (2020-2031)
Figure 28. Germany Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Digital Therapeutics for Psychiatric Illnesses Market Share by Region (2020-2031)
Figure 36. China Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Digital Therapeutics for Psychiatric Illnesses Market Share by Country (2020-2031)
Figure 44. Mexico Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Share by Country (2020-2031)
Figure 48. Turkey Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Pear Therapeutics Revenue Growth Rate in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)
Figure 52. Akili Interactive Revenue Growth Rate in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)
Figure 53. Big Health Revenue Growth Rate in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)
Figure 54. Click Therapeutics Revenue Growth Rate in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)
Figure 55. Orexo Revenue Growth Rate in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)
Figure 56. Limbix Revenue Growth Rate in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)
Figure 57. Cognoa Revenue Growth Rate in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)
Figure 58. Freespira Revenue Growth Rate in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)
Figure 59. Shandong Xindao Artificial Intelligence Technology Co., Ltd. Revenue Growth Rate in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Digital Therapeutics for Psychiatric Illnesses Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Prevention
Table 3. Key Players of Management
Table 4. Key Players of Treatment
Table 5. Global Digital Therapeutics for Psychiatric Illnesses Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Digital Therapeutics for Psychiatric Illnesses Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Digital Therapeutics for Psychiatric Illnesses Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Digital Therapeutics for Psychiatric Illnesses Market Share by Region (2020-2025)
Table 9. Global Digital Therapeutics for Psychiatric Illnesses Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Digital Therapeutics for Psychiatric Illnesses Market Share by Region (2026-2031)
Table 11. Digital Therapeutics for Psychiatric Illnesses Market Trends
Table 12. Digital Therapeutics for Psychiatric Illnesses Market Drivers
Table 13. Digital Therapeutics for Psychiatric Illnesses Market Challenges
Table 14. Digital Therapeutics for Psychiatric Illnesses Market Restraints
Table 15. Global Digital Therapeutics for Psychiatric Illnesses Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Digital Therapeutics for Psychiatric Illnesses Market Share by Players (2020-2025)
Table 17. Global Top Digital Therapeutics for Psychiatric Illnesses Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Therapeutics for Psychiatric Illnesses as of 2024)
Table 18. Ranking of Global Top Digital Therapeutics for Psychiatric Illnesses Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Digital Therapeutics for Psychiatric Illnesses Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Digital Therapeutics for Psychiatric Illnesses, Headquarters and Area Served
Table 21. Global Key Players of Digital Therapeutics for Psychiatric Illnesses, Product and Application
Table 22. Global Key Players of Digital Therapeutics for Psychiatric Illnesses, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Digital Therapeutics for Psychiatric Illnesses Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Digital Therapeutics for Psychiatric Illnesses Revenue Market Share by Type (2020-2025)
Table 26. Global Digital Therapeutics for Psychiatric Illnesses Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Digital Therapeutics for Psychiatric Illnesses Revenue Market Share by Type (2026-2031)
Table 28. Global Digital Therapeutics for Psychiatric Illnesses Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Digital Therapeutics for Psychiatric Illnesses Revenue Market Share by Application (2020-2025)
Table 30. Global Digital Therapeutics for Psychiatric Illnesses Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Digital Therapeutics for Psychiatric Illnesses Revenue Market Share by Application (2026-2031)
Table 32. North America Digital Therapeutics for Psychiatric Illnesses Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Digital Therapeutics for Psychiatric Illnesses Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Digital Therapeutics for Psychiatric Illnesses Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Digital Therapeutics for Psychiatric Illnesses Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Digital Therapeutics for Psychiatric Illnesses Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Digital Therapeutics for Psychiatric Illnesses Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2026-2031) & (US$ Million)
Table 47. Pear Therapeutics Company Details
Table 48. Pear Therapeutics Business Overview
Table 49. Pear Therapeutics Digital Therapeutics for Psychiatric Illnesses Product
Table 50. Pear Therapeutics Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025) & (US$ Million)
Table 51. Pear Therapeutics Recent Development
Table 52. Akili Interactive Company Details
Table 53. Akili Interactive Business Overview
Table 54. Akili Interactive Digital Therapeutics for Psychiatric Illnesses Product
Table 55. Akili Interactive Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025) & (US$ Million)
Table 56. Akili Interactive Recent Development
Table 57. Big Health Company Details
Table 58. Big Health Business Overview
Table 59. Big Health Digital Therapeutics for Psychiatric Illnesses Product
Table 60. Big Health Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025) & (US$ Million)
Table 61. Big Health Recent Development
Table 62. Click Therapeutics Company Details
Table 63. Click Therapeutics Business Overview
Table 64. Click Therapeutics Digital Therapeutics for Psychiatric Illnesses Product
Table 65. Click Therapeutics Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025) & (US$ Million)
Table 66. Click Therapeutics Recent Development
Table 67. Orexo Company Details
Table 68. Orexo Business Overview
Table 69. Orexo Digital Therapeutics for Psychiatric Illnesses Product
Table 70. Orexo Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025) & (US$ Million)
Table 71. Orexo Recent Development
Table 72. Limbix Company Details
Table 73. Limbix Business Overview
Table 74. Limbix Digital Therapeutics for Psychiatric Illnesses Product
Table 75. Limbix Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025) & (US$ Million)
Table 76. Limbix Recent Development
Table 77. Cognoa Company Details
Table 78. Cognoa Business Overview
Table 79. Cognoa Digital Therapeutics for Psychiatric Illnesses Product
Table 80. Cognoa Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025) & (US$ Million)
Table 81. Cognoa Recent Development
Table 82. Freespira Company Details
Table 83. Freespira Business Overview
Table 84. Freespira Digital Therapeutics for Psychiatric Illnesses Product
Table 85. Freespira Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025) & (US$ Million)
Table 86. Freespira Recent Development
Table 87. Shandong Xindao Artificial Intelligence Technology Co., Ltd. Company Details
Table 88. Shandong Xindao Artificial Intelligence Technology Co., Ltd. Business Overview
Table 89. Shandong Xindao Artificial Intelligence Technology Co., Ltd. Digital Therapeutics for Psychiatric Illnesses Product
Table 90. Shandong Xindao Artificial Intelligence Technology Co., Ltd. Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025) & (US$ Million)
Table 91. Shandong Xindao Artificial Intelligence Technology Co., Ltd. Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
Table 95. Authors List of This Report
List of Figures
Figure 1. Digital Therapeutics for Psychiatric Illnesses Picture
Figure 2. Global Digital Therapeutics for Psychiatric Illnesses Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Digital Therapeutics for Psychiatric Illnesses Market Share by Type: 2024 VS 2031
Figure 4. Prevention Features
Figure 5. Management Features
Figure 6. Treatment Features
Figure 7. Global Digital Therapeutics for Psychiatric Illnesses Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Digital Therapeutics for Psychiatric Illnesses Market Share by Application: 2024 VS 2031
Figure 9. Insomnia Case Studies
Figure 10. Depression Case Studies
Figure 11. Autistic Case Studies
Figure 12. Anxiety Disorder Case Studies
Figure 13. Schizophrenia Case Studies
Figure 14. Other Case Studies
Figure 15. Digital Therapeutics for Psychiatric Illnesses Report Years Considered
Figure 16. Global Digital Therapeutics for Psychiatric Illnesses Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Digital Therapeutics for Psychiatric Illnesses Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Digital Therapeutics for Psychiatric Illnesses Market Share by Region: 2024 VS 2031
Figure 19. Global Digital Therapeutics for Psychiatric Illnesses Market Share by Players in 2024
Figure 20. Global Top Digital Therapeutics for Psychiatric Illnesses Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Therapeutics for Psychiatric Illnesses as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Digital Therapeutics for Psychiatric Illnesses Revenue in 2024
Figure 22. North America Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Digital Therapeutics for Psychiatric Illnesses Market Share by Country (2020-2031)
Figure 24. United States Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Digital Therapeutics for Psychiatric Illnesses Market Share by Country (2020-2031)
Figure 28. Germany Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Digital Therapeutics for Psychiatric Illnesses Market Share by Region (2020-2031)
Figure 36. China Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Digital Therapeutics for Psychiatric Illnesses Market Share by Country (2020-2031)
Figure 44. Mexico Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Share by Country (2020-2031)
Figure 48. Turkey Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Pear Therapeutics Revenue Growth Rate in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)
Figure 52. Akili Interactive Revenue Growth Rate in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)
Figure 53. Big Health Revenue Growth Rate in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)
Figure 54. Click Therapeutics Revenue Growth Rate in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)
Figure 55. Orexo Revenue Growth Rate in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)
Figure 56. Limbix Revenue Growth Rate in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)
Figure 57. Cognoa Revenue Growth Rate in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)
Figure 58. Freespira Revenue Growth Rate in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)
Figure 59. Shandong Xindao Artificial Intelligence Technology Co., Ltd. Revenue Growth Rate in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232